Literature DB >> 8819054

Post-therapy antibody titers in dogs with ehrlichiosis: follow-up study on 68 patients treated primarily with tetracycline and/or doxycycline.

R C Bartsch1, R T Greene.   

Abstract

The clinical and serological responses to therapy were evaluated for at least 1 year in 68 dogs with antibody titers positive for Ehrlichia canis. Treatments were of variable periods with primarily tetracycline hydorchloride and/or doxycycline. Sixteen dogs had initial titers of 1:20 and, at the end of the year, were asymptomatic, no longer receiving medication, and had negative serology. The average length of treatment with tetracycline HCl and/or doxycycline was 85 days (range, 14 to 360 days). Of 39 dogs with initial titers of 1:2,560 or greater, 1 died, 25 were asymptomatic, and 13 were lost to follow-up at the end of the study. The average length of treatment was 210 days (range, 21 to 630 days). Twenty-seven dogs were seropositive at > or = 1:2,560 when the sera was last tested. Thirteen dogs had initial titers of 1:80 to 1:1,280. Of these 13 dogs, 2 died, 2 were lost to follow-up, and 9 were asymptomatic and had titers ranging from negative to > or = 1:2,560 at the end of the study. The persistence of antibodies, prolonged subclinical phase, and delayed relapses despite long-term medication, suggest inadequate chemotherapeutic agents or may be natural features of latency of ehrlichiosis in dogs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8819054     DOI: 10.1111/j.1939-1676.1996.tb02061.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  12 in total

1.  Efficacy of a doxycycline treatment regimen initiated during three different phases of experimental ehrlichiosis.

Authors:  Jennifer C McClure; Michelle L Crothers; John J Schaefer; Patrick D Stanley; Glen R Needham; S A Ewing; Roger W Stich
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

2.  Comparison of simultaneous splenic sample PCR with blood sample PCR for diagnosis and treatment of experimental Ehrlichia canis infection.

Authors:  Shimon Harrus; Martin Kenny; Limor Miara; Itzhak Aizenberg; Trevor Waner; Susan Shaw
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

3.  Doxycycline hyclate treatment of experimental canine ehrlichiosis followed by challenge inoculation with two Ehrlichia canis strains.

Authors:  E B Breitschwerdt; B C Hegarty; S I Hancock
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

4.  Sequential evaluation of dogs naturally infected with Ehrlichia canis, Ehrlichia chaffeensis, Ehrlichia equi, Ehrlichia ewingii, or Bartonella vinsonii.

Authors:  E B Breitschwerdt; B C Hegarty; S I Hancock
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

5.  Clinical, serological, and molecular evidence of ehrlichiosis and anaplasmosis in dogs in Tunisia.

Authors:  Y M'ghirbi; A Ghorbel; M Amouri; A Nebaoui; S Haddad; A Bouattour
Journal:  Parasitol Res       Date:  2008-11-19       Impact factor: 2.289

6.  Tick acquisition of Ehrlichia canis from dogs treated with doxycycline hyclate.

Authors:  John J Schaefer; Glen R Needham; William G Bremer; Yasuko Rikihisa; S A Ewing; R W Stich
Journal:  Antimicrob Agents Chemother       Date:  2007-07-02       Impact factor: 5.191

7.  Interstitial pneumonia and pulmonary hypertension associated with suspected ehrlichiosis in a dog.

Authors:  Marjolein Lisette den Toom; Tetyda Paulina Dobak; Els Marion Broens; Chiara Valtolina
Journal:  Acta Vet Scand       Date:  2016-07-07       Impact factor: 1.695

8.  Ehrlichiosis, babesiosis, anaplasmosis and hepatozoonosis in dogs from St. Kitts, West Indies.

Authors:  Patrick J Kelly; Chuanling Xu; Helene Lucas; Amanda Loftis; Jamie Abete; Frank Zeoli; Audrey Stevens; Kirsten Jaegersen; Kate Ackerson; April Gessner; Bernhard Kaltenboeck; Chengming Wang
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

9.  First report of Babesia gibsoni in Central America and survey for vector-borne infections in dogs from Nicaragua.

Authors:  Lanjing Wei; Patrick Kelly; Kate Ackerson; Jilei Zhang; Heba S El-Mahallawy; Bernhard Kaltenboeck; Chengming Wang
Journal:  Parasit Vectors       Date:  2014-03-25       Impact factor: 3.876

Review 10.  Ehrlichioses: An Important One Health Opportunity.

Authors:  Tais B Saito; David H Walker
Journal:  Vet Sci       Date:  2016-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.